New research suggests that statins, a common medication for managing cardiovascular risk, may be worsening menopause symptoms in postmenopausal women. The study, which analyzed data from 1,184 postmenopausal women across nine Latin American countries, found that those taking statins were 56% more likely to report severe menopausal symptoms compared to women not on the medication.
Statins are widely prescribed to lower cholesterol and reduce the risk of heart disease. However, the U.S. Food and Drug Administration has flagged potential side effects that can resemble menopause complaints, such as muscle pain and cognitive changes. Researchers sought to determine whether these overlapping effects appear in real-world data by assessing menopausal symptoms, sarcopenia risk, and cognitive function in statin users and non-users, while accounting for factors like age and body weight.
The study, published as a cross-sectional analysis, can identify associations but cannot prove that statins directly cause these outcomes. Results showed that statin users were also 65% more likely to be at risk for sarcopenia, the gradual loss of muscle mass and physical function that accelerates after menopause. Muscle loss at this stage is already a concern due to declining estrogen levels, and it is linked to a higher risk of falls, fractures, and reduced quality of life.
Additionally, statin users reported more intense musculoskeletal symptoms, with 53.1% experiencing such issues compared to 33.9% of non-users. This finding points to a broader pattern of physical discomfort that may be overlooked in women on statins. On the cognitive side, statin users showed slightly lower scores on delayed memory recall and visuospatial function tests, though no overall link to mild cognitive impairment was found, making these early signals worth monitoring rather than firm conclusions.
The researchers noted that statin-related effects may overlap with menopause symptoms, potentially compounding each other. Symptoms women attribute to menopause, such as hot flashes, night sweats, and joint pain, can look similar to statin side effects. Untangling the two remains an open area of research.
Implications for Postmenopausal Women
This research does not suggest that women should stop taking statins, as their cardiovascular benefits are well-established. Stopping medication without medical guidance can carry serious risks. Instead, the study offers a fuller picture of what statin therapy might mean for postmenopausal women, a group historically underrepresented in cardiovascular research.
Women on statins who find their menopause symptoms more intense than expected, or who notice changes in muscle strength or physical function, are advised to discuss these concerns with their doctors. Questions to consider include whether symptoms are consistent with statin use, whether screening for muscle loss is needed, whether the current statin is the best option given its side-effect profile, and what steps can be taken to protect muscles, such as resistance training and adequate protein intake.
The takeaway is that statins are life-saving for many, but their side effects deserve more attention, particularly in postmenopausal women. This study adds to evidence that midlife women need more individualized care, and if something feels off, it is worth investigating further.
